HIV coinfection with hepatitis b other diagnostic studies

Revision as of 18:01, 18 September 2017 by WikiBot (talk | contribs) (Changes made per Mahshid's request)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

HIV coinfection with hepatitis b Microchapters

Home

Patient Information

Overview

Pathophysiology

Causes

Differentiating HIV coinfection with hepatitis b from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

HIV coinfection with hepatitis b other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of HIV coinfection with hepatitis b other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on HIV coinfection with hepatitis b other diagnostic studies

CDC on HIV coinfection with hepatitis b other diagnostic studies

HIV coinfection with hepatitis b other diagnostic studies in the news

Blogs on HIV coinfection with hepatitis b other diagnostic studies

Directions to Hospitals Treating HIV coinfection with hepatitis b

Risk calculators and risk factors for HIV coinfection with hepatitis b other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Other Diagnostic Studies

Liver Biopsy

Liver biopsy remains the gold standard for assessing disease severity in HIV-HBV coinfection. Non-invasive markers are also available but none have been widely studied in coinfected patients.

References